Pfizer Limited
PFIZER · Pharma · NSE
₹4,551
Current Market Price
Fair Value (DCF)
₹3,725
Discount to FV
-18.1%
Updated just now
YieldIQ Score
43/100
Piotroski F-Score
6/9
Economic Moat
Moderate
Confidence
72%
ROE
18.2%
Debt/Equity
0.03
WACC
9.5%
Market Cap
₹20,820 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
25.1%
Return on capital employed
EV / EBITDA
20.1×
Enterprise multiple
Debt / EBITDA
0.1×
Leverage vs earnings
Interest Coverage
103.9×
EBIT covers interest
Current Ratio
6.06×
Short-term liquidity
Asset Turnover
0.51×
Revenue per ₹ of assets
Revenue CAGR (3Y)
1.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹4,551.1
Bear case
Discount -365.2%
Base case
Discount -22.2%
Bull case
Discount -1.8%
Ratio Trends
PFIZER · last 8 annual periods
ROE
18.2%
ROCE
25.1%
Operating Margin
—
Debt / Equity
0.03×
PE
122.3×
EV / EBITDA
16.8×
Historical Financials
PFIZER · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2611 Cr | ₹2422 Cr | ₹2193 Cr | ₹2281 Cr | ₹2520 Cr | -0.9% |
| EBITDA | ₹898 Cr | ₹943 Cr | ₹824 Cr | ₹1085 Cr | ₹1043 Cr | +3.8% |
| EBIT | ₹783 Cr | ₹837 Cr | ₹761 Cr | — | — | -0.7% |
| PAT | ₹613 Cr | ₹624 Cr | ₹551 Cr | ₹768 Cr | ₹722 Cr | +4.2% |
| EPS (diluted) | ₹133.89 | ₹136.38 | ₹120.51 | — | — | -2.6% |
| CFO | ₹667 Cr | ₹356 Cr | ₹257 Cr | ₹660 Cr | ₹968 Cr | +9.7% |
| CapEx | ₹-15.3 Cr | ₹-65.0 Cr | ₹-18.9 Cr | ₹-28.1 Cr | ₹-25.2 Cr | — |
| FCF | ₹652 Cr | ₹291 Cr | ₹238 Cr | ₹632 Cr | ₹942 Cr | +9.7% |
| Total Assets | ₹3901 Cr | ₹4001 Cr | ₹4229 Cr | ₹4911 Cr | ₹4922 Cr | +6.0% |
| Total Debt | ₹167 Cr | ₹134 Cr | ₹94.5 Cr | ₹108 Cr | ₹70.2 Cr | -19.5% |
| Shareholders' Equity | ₹2864 Cr | ₹3207 Cr | ₹3596 Cr | ₹4217 Cr | ₹4203 Cr | +10.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
PFIZER vs 1 closest peer by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 GLAXO GLAXO | — | — | Pending | 45.7% | 37.3× |
Click a ticker to view its fair-value analysis.
Dividend History
12 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹340.00/sh
Last payout
2025-07-09
₹165.00
Peak payout
₹320.00
Trailing yield
3.63%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of PFIZER →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for PFIZER →
Compare
Head-to-head with peers
Compare PFIZER side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse PFIZERNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.